Hi Folks. I’ve got this back on my radar.
Correct me if I’m wrong but it looks like PTX100 is the only game in town now with Cell-Pryme under development but in an out of favor segment, for now.
If they are going to run a phase2 they will need significantly more capital, so they will be gearing up for an announcement this year, imo.
PTX100 looks good. Has anyone run analysis on other competitors in the pipeline?
They have a mountain to climb and it could be long waits between news.
This could be about bottom of the cycle here.
Interested in others opinions
Hi Folks. I’ve got this back on my radar. Correct me if I’m...
Add PTX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
-0.001(2.50%) |
Mkt cap ! $31.40M | |||
| Open | High | Low | Value | Volume |
| 4.1¢ | 4.1¢ | 3.9¢ | $72.73K | 1.802M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 436541 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.1¢ | 560576 | 1 |
View Market Depth
| Last trade - 15.59pm 15/11/2024 (20 minute delay) ? |
| PTX (ASX) Chart |